Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

383 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety evaluation of fixed-dose nivolumab in patients with gastric cancer.
Iikura Y, Aoyama T, Hiraide M, Wakatsuki T, Nakayama I, Ogura M, Ooki A, Takahari D, Chin K, Yamaguchi K, Hama T. Iikura Y, et al. Among authors: hama t. Health Sci Rep. 2022 Jun 3;5(4):e673. doi: 10.1002/hsr2.673. eCollection 2022 Jul. Health Sci Rep. 2022. PMID: 35662976 Free PMC article.
Comparison of cisplatin-induced nephrotoxicity when using conventional versus short hydration in gastric cancer-a retrospective study.
Aoyama T, Tsunoda T, Kato H, Hagino A, Furutani R, Ito K, Yoshioka H, Nakamura M, Hiraide M, Kawakami K, Kobayashi K, Suzuki K, Ichimura T, Yamaguchi K, Hama T. Aoyama T, et al. Among authors: hama t. J Chemother. 2020 May;32(3):144-150. doi: 10.1080/1120009X.2020.1713507. Epub 2020 Jan 21. J Chemother. 2020. PMID: 31960769
Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and ABCG2 polymorphisms in patients with metastatic colorectal cancers.
Kobayashi K, Sugiyama E, Shinozaki E, Wakatsuki T, Tajima M, Kidokoro H, Aoyama T, Nakano Y, Kawakami K, Hashimoto K, Suenaga M, Ichimura T, Ogura M, Chin K, Nakayama I, Ooki A, Takahari D, Suzuki W, Yokokawa T, Minowa Y, Hiraoka T, Suzuki K, Sato H, Hama T, Yamaguchi K. Kobayashi K, et al. Among authors: hama t. Cancer Chemother Pharmacol. 2021 Jun;87(6):767-777. doi: 10.1007/s00280-021-04237-x. Epub 2021 Feb 26. Cancer Chemother Pharmacol. 2021. PMID: 33635392
Regorafenib-Induced Hand-Foot Skin Reaction Is More Severe on the Feet Than on the Hands.
Nonomiya Y, Yokokawa T, Kawakami K, Kobayashi K, Aoyama T, Takiguchi T, Sugisaki T, Suzuki K, Suenaga M, Wakatsuki T, Yamaguchi K, Sugimoto Y, Hama T. Nonomiya Y, et al. Among authors: hama t. Oncol Res. 2019 May 7;27(5):551-556. doi: 10.3727/096504018X15291727589740. Epub 2018 Jun 18. Oncol Res. 2019. PMID: 29914591 Free PMC article.
383 results